Chromogranins from Cell Biology to Physiology and Biomedicine

257 Large secretory vesicles are still accumulating CA even in the absence of Cgs. Although amine concentration resulted halved ...

258 Blaschko H, Comline RS, Schneider FH, Silver M, Smith AD (1967) Secretion of a chromaffin granule protein, chromogranin, fro ...

259 Iacangelo AL, Eiden LE (1995) Chromogranin A: current status as a precursor for bioactive pep- tides and a granulogenic/sort ...

260 Taupenot L, Harper KL, O’Connor DT (2003) The chromogranin-secretogranin family. N Engl J Med 348:1134–1149 Taupenot L, Harp ...

© Springer International Publishing AG 2017 261 T. Angelone et al. (eds.), Chromogranins: from Cell Biology to Physiology and Bi ...

262 Cardioprotection, CgA derived peptides (cont.) ischemic preconditioning, 175–178 natriuretic peptide, 171 neuroendocrine reg ...

263 processing of, 115 bovine CGs, 51 DV vs. NDV, 52–53 human CGA, endogenous cleavage sites of, 53 PMNs, 51–52 receptors, 10–11 ...

264 High performance liquid chromatography (HPLC), 214 Histamine, 161 Host defense peptides (HDPs), 50, 51 Human chromogranin A ...

265 Multidrug antibiotic resistance, 50 Multiple myeloma, 90 Myocardial ischemia/reperfusion injury, 173 N National Institute of ...

266 Secretogranin II (SgII) biomarker and disease CNS diseases, 28 SN serum levels, heart failure, 28 tumors, 27–28 gene organis ...

267 Tumors, 28 chromogranin A, 84, 90–92 secretogranin II, 27–28 Type-2 diabetes, 44 V Vascular endothelial growth factor (VEGF) ...